Advertisement

Picture BCNP Consultants European Chemistry Partnering 2018 Ffm Germany 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 2463 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Probiodrug–BIO (US): partnering conference, 201706 supply service Probiodrug Presents at BIO International Convention 2017-06-19
Bayer–China (govt): wheat breeding, 201706– collab 2y with SIBS + SIPPE to improve wheat yields via improved photosynthetic efficiency 2017-06-14
Bruker Corp–Goldman Sachs: investor conference, 201706 supply service Bruker presents at 38th Annual Global Healthcare Conference 2017-06-14
MorphoSys–Deutsche Bank: investor conference, 201706 supply service MorphoSys presents at dbAccess Berlin Conference 2017-06-14
MorphoSys–Goldman Sachs: investor conference, 201706 supply service MorphoSys presents at 38th Annual Global Healthcare Conference 2017-06-14
Bruker Corp–William Blair: investor conference, 201706 supply service Bruker presents at William Blair Annual Growth Stock Conference in Chicago 2017-06-13
Centogene–Careventures: investment, 201706 financing round Series A totalling €25m incl co-investor Careventures 2017-06-13
Centogene–Crédit Mutuel-CIC: investment, 201706 financing round Series A totalling €25m incl co-investor CIC Capital 2017-06-13
Centogene–DPE Deutsche Private Equity: investment, 201706 financing round Series A totalling €25m incl co-investor DPE 2017-06-13
Centogene–SEVERAL: investment, 201706 financing round Series A €25m led by TVM Capital + incl DPE + Careventures + CIC Capital 2017-06-13
Centogene–TVM: investment, 201706 financing round Series A totalling €25m incl lead investor TVM Capital Life Science 2017-06-13
CureVac–TiberendStrategic Advisors: public relations, 201706 service existent by Tiberend 2017-06-13
Bruker Corp–Leucadia: investor conference, 201706 supply service Bruker presents at Jefferies Healthcare Conference in New York 2017-06-08
Lilly–Nordic Bioscience: antidiabetic, 201706– strategic collab $55m upfront + milestones + royalties ww rights to develop DACRAs from KeyBioscience 2017-06-08
Grünenthal–AstraZeneca: zolmitriptan, 201706 acquisition ww rights excl JP to Zomig $200m upfront + $102m milestones by Grünenthal 2017-06-07
Omeicos Therapeutics–Germany (govt): grant, 201706– additional BMBF research grant €1.7m 2017-06-07
CRISPR Therapeutics–Orgenesis: CAR-T cell therapies, 201706– supply CDMO services for allogenic CAR-T therapy CTX101 by MaSTherCell SA 2017-06-06
Probiodrug–Leucadia: investor conference, 201706 supply service Probiodrug presents at Jefferies Healthcare Conference in New York 2017-06-06
Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201706– collab co-marketing of new AbsoluteIDQ p400 HR Kit with Q Exactive HRAM MS systems 2017-06-05
Thermo Fisher–Biognosys: mass spectrometry s/w, 201706– collab co-marketing of Spectronaut Pulsar s/w with Orbitrap mass spectrometers 2017-06-05
Univ Maastricht–Bruker Corp: mass spectrometry software, 201706 supply existent use of SCilS Lab s/w by M4I 2017-06-05
Merck (DE)–F-Star: antibody cancer drug, 201706– strategic collab to develop 5 bispecific antibodies incl lead asset FS118 2017-06-04
BMS–Qiagen: molecular companion diagnostics, 201706– collab using NGS to develop gene expression profiles for cancer immunotherapies 2017-06-03
Qiagen–Johns Hopkins Univ: cancer biomarker, 201705– license ww to genetic biomarkers for use in I-O patient selection 2017-06-03
GATC Biotech–Eurofins: investment, 201706–201707 acquisition €na of GATC Biotech AG by Eurofins Scientific SE 2017-06-02
Bicycle Therapeutics–SEVERAL: investment, 201706 financing round Series B £40m led by new investor Vertex Ventures HC 2017-06-01
Indivumed–LADR/Intermed: investment, 201706 investment by Intermed as part of strategic alliance 2017-06-01
Inthera Bioscience–SEVERAL: investment, 201705 financing round Series A CHF10.5m Merck Ventures + Aglaia BioMedical + Novo Seeds + private investor 2017-05-31
Strekin–SEVERAL: investment, 201705 financing round Series C CHF10m from private investors 2017-05-31
High-Tech Gründerfonds–SEVERAL: investment, 201705 first closing €245m of High-Tech Gründerfonds III (HTGF III) 2017-05-30
Taconic–ERS Genomics: CRISPR technology, 201705– license ww non-excl for CRISPR-Cas9 technology to generate murine models 2017-05-30
Wise (IT)–SEVERAL: investment, 201705 financing round Series B €6.5m led by Prinicpia SGR + incl Atlante Ventures + HTGF + F3F + Antares 2017-05-25
Debiopharm–ImmunoGen: antibody-drug conjugate, 201704 acquisition $25m upfront + $30m milestones of anti-CD37 ADC IMGN529 by Debiopharm 2017-05-24
MorphoSys–Berenberg: investor conference, 201705 supply service MorphoSys presents at Berenberg European Conference USA in Tarrytown 2017-05-24
Sartorius–SEVERAL: credit, 201705– note loan €350m with maturity terms of 5, 7 + 10 years arranged by Commerzbank + LBBW 2017-05-24
CRISPR Therapeutics–UBS: investor conference, 201705 supply service CRISPR Tx presents at UBS Global Healthcare Conference NY 2017-05-23
Helsinn–UBS: investor conference, 201705 supply service Helsinn Therapeutics (U.S.) Inc presents at UBS Global Healthcare Conference NY 2017-05-23
OSE Immunotherapeutics–Selexis: cell line development, 201705– commercial license for access to RCBs from SUREtechnology platform 2017-05-23
Signatope–High-Tech Gründerfonds: investment, 201705 investment €600k by HTGF 2017-05-23
TolerogenixX–High-Tech Gründerfonds: investment, 201705 seed financing from HTGF 2017-05-23
CureVac–Informa: investor conference, 201705 supply service CureVac presents at BioEquity Europe 2017 in Paris 2017-05-22
CureVac–UBS: investor conference, 201705 supply service CureVac presents at UBS Global Healthcare Conference NY 2017-05-22
Editas Medicine–UBS: investor conference, 201705 supply service Editas presents at UBS Global Healthcare Conference NY 2017-05-22
Medigene–Informa: investor conference, 201705 supply service Medigene presents at BioEquity Europe 2017 in Paris 2017-05-22
MorphoSys–UBS: investor conference, 201705 supply service MorphoSys presents at UBS Global Healthcare Conference NY 2017-05-22
Probiodrug–Informa: investor conference, 201705 supply service Probiodrug presents at BioEquity Europe 2017 in Paris 2017-05-22
Probiodrug–UBS: investor conference, 201705 supply service Probiodrug presents at UBS Global Healthcare Conference NY 2017-05-22
Uniqure–UBS: investor conference, 201705 supply service Uniqure presents at UBS Global Healthcare Conference NY 2017-05-22
Boehringer–Anagenesis: drug discovery technology, 201705– excl license to P2MC technology for drug developm for chronic muscle diseases 2017-05-18
CRISPR Therapeutics–Bank of America: investor conference, 201705 supply service CRISPR Tx presents at BAML Health Care Conference Las Vegas 2017-05-17
Boehringer–Peking Univ: pharma r+d, 201705– collab strategic alliance incl therapeutics + regenerative medicine + gene therapy 2017-05-16
Exosomics Siena–Lonza: investment, 201705 strategic investment by Lonza 2017-05-16
HansaBioMed Life Sciences–Lonza: investment, 201705 acquisition of HBM-LS by Lonza 2017-05-16
Vesalius Biocapital–SEVERAL: investment, 201705 first closing €65m of Vesalius Biocapital III fund 2017-05-15
Cardior Pharmaceuticals–SEVERAL: investment, 201705 financing round Series A €15m led by LSP + BIVF + BMS + BioMedPartners + HTGF 2017-05-11
BC Platforms–Debiopharm: investment, 201705 financing round Series B totalling $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
BC Platforms–SEVERAL: investment, 201705 financing round Series B $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
BC Platforms–Tesi (FI): investment, 201705 financing round Series B totalling $10m co-led by Debiopharm Innovation Fund + Tesi 2017-05-09
Grzybowski Scientific Inventions–Merck (DE): investment, 201705 acquisition of GSI by Merck 2017-05-09
Aadi Bioscience–Helsinn: investment, 201705 financing round Series A totalling $23m incl $2m from co-investor Helsinn Investment Fund 2017-05-08
Aadi Bioscience–SEVERAL: investment, 201705 financing round Series A $23m led by Hermed Capital with Celgene + Vivo Capital + Helsinn et al 2017-05-08
CRISPR Therapeutics–MIT: lipid nanoparticle technolgy, 201705– excl license for family of LNP technologies for in vivo gene editing applications 2017-05-08
Genetrix (ES)–SEVERAL: investment, 201705– capital increase up to €10m w rights offering + private placement Sygnis AG 2017-05-08
Innova Biosciences–Genetrix (ES): investment, 201705– acquisition €8m cash + 2m Sygnis shares plus up to 1.5m shares by Sygnis AG ANNOUNCED 2017-05-08
Luxendo–Bruker Corp: investment, 201705 acquisition €na of Luxendo GmbH by Bruker 2017-05-08
Bruker Corp–Deutsche Bank: investor conference, 201705 supply service Bruker presents at Deutsche Bank Annual Health Care Conference 2017-05-04
Celyad–Deutsche Bank: investor conference, 201705 supply service Celyad presents at Deutsche Bank Annual Health Care Conference 2017-05-04
Medigene–SEVERAL: investment, 201705 private placement €20.7m 1.965m new shares at €10.55/share to institutional investors 2017-05-04
MVZ für Laboratoriumsmedizin am Hygiene-Institut–Eurofins: investment, 201705– acquisition of Hygel by Eurofins ANNOUNCED 2017-05-04
Vivet Therapeutics–Columbus Venture Partners: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor CVP 2017-05-04
Vivet Therapeutics–Kurma: investment, 201705 financing round Series A totalling €37.5m incl co-investor Kurma Partners 2017-05-04
Vivet Therapeutics–Novartis: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor Novartis Venture Fund 2017-05-04
Vivet Therapeutics–Odlander Fredrikson: investment, 201705 financing round Series A totalling €37.5m incl co-investor HealthCap 2017-05-04
Vivet Therapeutics–Roche: investment, 201705 financing round Series A totalling €37.5m incl co-investor Roche Venture Fund 2017-05-04
Vivet Therapeutics–SEVERAL: investment, 201705 financing round Series A €37.5m led by Novartis Venture Fund + Columbus Venture Partners 2017-05-04
Vivet Therapeutics–Ysios Capital: investment, 201705 financing round Series A totalling €37.5m incl co-investor Ysios Capital 2017-05-04
AstraZeneca–Pieris: anticalin technology, 201705– collab developm + commerc $57.5m upfront + near-term inhaled respiratory drugs incl PRS-060 2017-05-03
Bio-Techne–Deutsche Bank: investor conference, 201705 supply service Bio-Techne presents at Deutsche Bank Annual Health Care Conference 2017-05-03
CRISPR Therapeutics–Deutsche Bank: investor conference, 201705 supply service CRISPR Tx presents at Deutsche Bank Annual Health Care Conference 2017-05-03
Probiodrug–Deutsche Bank: investor conference, 201705 supply service Probiodrug attends Deutsche Bank Annual Health Care Conference in Boston 2017-05-03
Adaptimmune–Deutsche Bank: investor conference, 201705 supply service Adaptimmune presents at Deutsche Bank Annual Health Care Conference 2017-05-02
ImCheck Therapeutics–Boehringer: investment, 201705 financing round Series A totalling €20m incl co-lead investor BIVF 2017-05-02
ImCheck Therapeutics–Gimv: investment, 201705 financing round Series A totalling €20m incl co-investor Gimv 2017-05-02
ImCheck Therapeutics–IDI Group: investment, 201705 financing round Series A totalling €20m incl co-lead investor Idinvest 2017-05-02
ImCheck Therapeutics–Kurma: investment, 201705 financing round Series A totalling €20m incl co-lead investor Kurma Partners 2017-05-02
ImCheck Therapeutics–Life Sciences Partners: investment, 201705 financing round Series A totalling €20m incl co-investor LSP 2017-05-02
ImCheck Therapeutics–SEVERAL: investment, 201705 financing round Series A €20m from BIVF + Kurma Partners + Idinvest + Gimv + LSP 2017-05-02
Magenta Therapeutics–Novartis: cell therapy product, 201705– license to MGTA-456 (HSC835) to expand cord blood stem cells for transplants 2017-05-02
Magenta Therapeutics–SEVERAL: investment, 201705 financing round Series B $50m led by GV + incl Atlas Venture + Third Rock Ventures et al 2017-05-02
Aduro Biotech–Univ Bonn: cancer immunotherapy, 201704– license for STING agonists via Provendis to Aduro Biotech 2017-04-27
Arsanis–SEVERAL: investment, 201704 financing round Series D $45.5m led by Gates Foundation + incl GV + Alexandria Venture Investments et al 2017-04-26
Epigenomics–SEVERAL: investment, 201704– public cash takeover offer €7.52/share valuing Epigenomics at €171m incl net cash by CFUC + Biochain 2017-04-26
Microsaic–SCPA GmbH: chromatography software, 201704– collab integration of 4000 MiD MS system with PrepCon 5 preparative data + control s/w 2017-04-26
EMBL–Enamine: chemical compound library, 201704– collab library synthesis + medical chemistry + biological services for cancer drug research 2017-04-25
KSK Diagnostics–Hamburg (govt): investment, 201704 financing round with HTGF + Innovationsstarter Fonds Hamburg 2017-04-24
KSK Diagnostics–High-Tech Gründerfonds: investment, 201704 financing round with HTGF + Innovationsstarter Fonds Hamburg 2017-04-24
KSK Diagnostics–SEVERAL: investment, 201704 financing round with HTGF + Innovationsstarter Fonds Hamburg 2017-04-24
Merck (DE)–Fresenius: investment, 201704– acquisition €170m cash + €500m milestones + royalties of Merck biosimilars business based in Vaud CH 2017-04-24
Wilex–SEVERAL: investment, 201704– capital increase €4.99m with rights issue to existing shareholders incl dievini Hopp 2017-04-24
BioInvent–Merck (DE): bioreactors, 201704 supply full line of Mobius single-use bioreators to BioInvent upstream facility in Lund 2017-04-20
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page



Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA September 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px